A metabolic pathway linked to slower aging is overactive in a deadly form of brain cancer, according to researchers. Their findings suggest that tweaking the pathway to treat cancer may affect other biological processes, such as aging.
A metabolic pathway linked to slower aging is overactive in a deadly form of brain cancer, according to researchers. Their findings suggest that tweaking the pathway to treat cancer may affect other biological processes, such as aging.